RESEARCH MONOGRAPH · KDC-MN-164

Theacrine

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

58/100

Caffeine-like alkaloid with anti-tolerance claims that need a lot more replication

Theacrine is 1,3,7,9-tetramethyluric acid, found in kucha tea (Camellia assamica var. kucha) at meaningful concentrations. Structurally it's a purine alkaloid like caffeine but oxidized at one position and with an extra methyl group, which changes the receptor profile.

Mechanism overlap with caffeine is partial. Theacrine does antagonize adenosine A1 and A2A receptors but with somewhat different selectivity, and there's a dopaminergic story too, with some preclinical work suggesting upregulation of dopaminergic tone in striatum at chronic dosing. The story everyone repeats is that theacrine doesnt produce tolerance the way caffeine does. That claim comes from one preclinical study and one short human study from the Compound Solutions group, both of which are too small to settle the question, but the proposed mechanism (different effects on A1/A2A receptor density, possibly some inverse-agonism on certain subtypes) is at least plausible.

Human data is thin. There's a handful of acute-dosing studies showing alertness and mood effects at 200-300mg, an absence of major cardiovascular signal at those doses, and combination studies with caffeine showing some synergy. None of it rises to the level where we'd say theacrine has a settled clinical profile.

Sourcing is where this gets interesting. Most commercial theacrine on the market is TeaCrine, a patented branded ingredient from Compound Solutions. Non-branded bulk theacrine is harder to find pure, and there have been reports of caffeine contamination in budget material. HPLC verification is doable but not as routine as for caffeine.

Safety profile looks OK at the doses studied. Long-term data doesnt really exist yet.

What we like: the anti-tolerance angle is mechanistically interesting and if it replicates, it's a real differentiator from caffeine. The combination synergy with caffeine is also real. What we dont like: the supplement industry has been running with the anti-tolerance claim aggressively while the literature supporting it is genuinely sparse, and most product positioning oversells what we actually know.

Worth keeping in the research library as a caffeine comparator. Just dont treat it as a replacement until the tolerance question gets settled with bigger trials.

Evidence: 42
Mechanism: 58
Reliability: 55
Safety: 70
Sourcing: 65
Value: 55
Signal: 60
Staying power: 55

Plain-language summary Intrigue 52 / 100

Theacrine is a methylxanthine alkaloid found in kucha tea. It produces stimulant effects similar to caffeine but with reportedly less tolerance development and longer duration. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Methylxanthine / kucha tea alkaloid

A methylxanthine present in kucha tea (Camellia kucha) with caffeine-like CNS effects but reduced tolerance development.

Abstract

Theacrine (1,3,7,9-tetramethyluric acid; CAS 2309-49-1) is a methylxanthine alkaloid present in kucha tea (Camellia kucha) and yerba mate. The compound has structural similarity to caffeine but with two additional methyl groups that produce a distinct pharmacology. Theacrine acts as an adenosine receptor antagonist (similar mechanism to caffeine) but with slower onset (peak effect at 1.5 to 2 hours) and reportedly slower tolerance development. The compound is sold as TeaCrine (Compound Solutions) for performance and energy applications. Reported research dose ranges in the literature span 100 to 300 mg.

Mechanism of action

Adenosine receptor antagonist; slower onset and reduced tolerance development relative to caffeine.

Reported research dose ranges

Reported research dose ranges in the literature span 100 to 300 mg.

References

Habowski SM, et al. The safety and efficacy of theacrine. J Int Soc Sports Nutr 2014.

Read the full monograph

Available as a research-use-only PDF download. Note: PDFs for newly added compounds may take a few hours to propagate after this article was published.

KDC-MN-164

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Theacrine

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs